# Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years

> **NCT01828489** · PHASE3 · UNKNOWN · sponsor: **Vastra Gotaland Region** · enrollment: 300 (estimated)

## Conditions studied

- Pediatric Acute Myeloblastic Leukemia

## Interventions

- **DRUG:** Randomisation course 1 mitoxantrone versus DaunoXome
- **DRUG:** Randomisation course 2 ADxE versus FLADx

## Key facts

- **NCT ID:** NCT01828489
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2018-03
- **Final completion:** 2023-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01828489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01828489, "Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01828489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*